Thesem Pet Bio, an animal medical device company, is
continually researching and developing effective
animal joint treatments
to improve the quality of life of animals
through the use of PDRN and PN,
the next-generation of animal joint treatments.
Thesem Pet Bio developed hyaluronic acid and collagen injections,
the first-ever treatments for animal joints developed in Korea.
We are a medical device company currently developing PDRN and PN products which are the next generation animal joint treatments.
Today, over 6 million Korean households have pets which is about 29.7% of all households in Korea.
More than one in four Koreans live with pets and embrace them as a family member.
We continue to develop solutions for families and consider your pets part of our family.
Thesem Pet Bio is committed to developing creative solutions for healthier pet families worldwide.
We appreciate your continued interest in Thesem Pet Bio.
CEO Doo-han Kang